Agios Pharmaceuticals
AGIO
AGIO
173 hedge funds and large institutions have $3.37B invested in Agios Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 59 increasing their positions, 68 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
13% less funds holding
Funds holding: 198 → 173 (-25)
13% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 68
59% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 41
Holders
173
Holding in Top 10
5
Calls
$33.7M
Puts
$23M
Top Buyers
| 1 | +$183M | |
| 2 | +$66.1M | |
| 3 | +$46M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$42.6M |
| 5 |
HM
HealthCor Management
New York
|
+$27.7M |
Top Sellers
| 1 | -$95.6M | |
| 2 | -$52.9M | |
| 3 | -$45.9M | |
| 4 |
CCM
Consonance Capital Management
New York
|
-$27.4M |
| 5 |
Goldman Sachs
New York
|
-$26.9M |